Bio Technology General - BTGC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio Technology General - BTGC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (1913)	8/19/1999 1:10:00 PM
From: Jim Oravetz	Read Replies (1) of 2028

Aug 2nd, Sims sells 60K more shares. As I speculated, contract rev. was up for the Q helping them report better revenue. They were also helped by problems with a competetors product allowing an >800% increase in the low margin sales of BTGC's drug. Some Jap. income started to trickle in and overseas sales of Oxdanrin (not Olsten) helped. I noticed that the diluted earning/share numbers are calculated with out the "out of the money" options being taken into account. Does anyone know if this is common or legal or report the numbers as such? Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next